What is Equifax Inc's earnings per share (EPS)?

Equifax Inc (EFX) reported diluted earnings per share of $5.32 for fiscal year 2025. This represents a 9.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Equifax Inc Financials

EFX

Trailing 12 months to June 30, 2026

Revenue $6.4B +10.3% YoY

Net Income $691.3M +8.1% YoY

EPS (Diluted) $5.68 +10.9% YoY

Free Cash Flow $1.1B +20.5% YoY

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 21, 2026 Currency USD FYE December

Equifax Inc (EFX) reported $6.4B in revenue over the twelve months to Jun 30, 2026, up 10.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EFX FY2025 2026-08-29

Cash conversion has rebounded faster than margins, while short-term liquidity remains tight despite lower long-term leverage.

Cash conversion has become the key swing factor: free cash flow moved from $133M in FY2022 to $1.13B in FY2025, with free-cash-flow margin reaching 18.7%. Operating cash flow of $1.62B versus net income of $660M shows that FY2025 cash production was shaped by non-cash accounting items and cash-flow timing, not just the reported profit line.

Revenue reached $6.07B in FY2025, yet operating margin was only 18.0%, showing that added scale has not restored the earlier earnings conversion. Gross margin recovered only modestly from 55.7% in FY2023 to 56.5% in FY2025, pointing to partial normalization rather than a return to the FY2021 cost structure.

FY2025 debt-to-equity was 0.9x while the current ratio was 0.6x, combining improved long-term leverage with a narrow short-term asset cushion. Buybacks and dividends totaled $1.16B while financing cash flow was -$1.06B, showing that substantial cash was directed to shareholders as the capital structure was being adjusted.

Financial Health Signals

Financial Health Score 56/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Equifax Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Equifax Inc has an operating margin of 18.0%, meaning the company retains $18 of operating profit per $100 of revenue. This strong profitability earns a score of 86/100, reflecting efficient cost management and pricing power. This is down from 18.3% the prior year.

Growth

Equifax Inc's revenue grew 6.9% year-over-year to $6.1B, a solid pace of expansion. This earns a growth score of 58/100.

Leverage

Equifax Inc has elevated debt relative to equity (D/E of 0.88), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 29/100, reflecting increased financial risk.

Liquidity

Equifax Inc's current ratio of 0.60 is below the typical benchmark, resulting in a score of 7/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Equifax Inc converts 18.7% of revenue into free cash flow ($1.1B). This strong cash generation earns a score of 80/100.

Returns

Equifax Inc earns a strong 14.3% return on equity (ROE), meaning it generates $14 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 77/100. This is up from 12.6% the prior year.

Altman Z-Score Safe

3.41

Equifax Inc scores 3.41, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($22.8B) relative to total liabilities ($7.1B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

8/9

Equifax Inc passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

2.45x

For every $1 of reported earnings, Equifax Inc generates $2.45 in operating cash flow ($1.6B OCF vs $660.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

5.16x

Equifax Inc earns $5.16 in operating income for every $1 of interest expense ($1.1B vs $212.3M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$6.1B

YoY+6.9%

5Y CAGR+8.0%

10Y CAGR+8.6%

Equifax Inc generated $6.1B in revenue in fiscal year 2025. This represents an increase of 6.9% from the prior year.

EBITDA

$1.8B

YoY+5.8%

5Y CAGR+11.1%

10Y CAGR+7.4%

Equifax Inc's EBITDA was $1.8B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 5.8% from the prior year.

Net Income

$660.3M

YoY+9.3%

5Y CAGR+4.9%

10Y CAGR+4.4%

Equifax Inc reported $660.3M in net income in fiscal year 2025. This represents an increase of 9.3% from the prior year.

EPS (Diluted)

$5.32

YoY+9.9%

5Y CAGR+4.6%

10Y CAGR+4.1%

Equifax Inc earned $5.32 per diluted share (EPS) in fiscal year 2025. This represents an increase of 9.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$1.1B

YoY+39.5%

5Y CAGR+16.7%

10Y CAGR+6.2%

Equifax Inc generated $1.1B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 39.5% from the prior year.

Cash & Debt

$180.8M

YoY+6.4%

5Y CAGR-36.0%

10Y CAGR+6.8%

Equifax Inc held $180.8M in cash against $4.1B in long-term debt as of fiscal year 2025.

Dividends Per Share

$1.89

YoY+21.2%

5Y CAGR+3.9%

10Y CAGR+5.0%

Equifax Inc paid $1.89 per share in dividends in fiscal year 2025. This represents an increase of 21.2% from the prior year.

Shares Outstanding

120M

YoY-3.0%

5Y CAGR-0.3%

10Y CAGR+0.1%

Equifax Inc had 120M shares outstanding in fiscal year 2025. This represents a decrease of 3.0% from the prior year.

Margins & Returns

Gross Margin

56.5%

YoY+0.8pp

5Y CAGR-1.5pp

Equifax Inc's gross margin was 56.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.8 percentage points from the prior year.

Operating Margin

18.0%

YoY-0.3pp

5Y CAGR+1.6pp

10Y CAGR-8.0pp

Equifax Inc's operating margin was 18.0% in fiscal year 2025, reflecting core business profitability. This is down 0.3 percentage points from the prior year.

Net Margin

10.9%

YoY+0.2pp

5Y CAGR-1.7pp

10Y CAGR-5.2pp

Equifax Inc's net profit margin was 10.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.2 percentage points from the prior year.

Return on Equity

14.3%

YoY+1.7pp

5Y CAGR-2.1pp

10Y CAGR-4.2pp

Equifax Inc's ROE was 14.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.7 percentage points from the prior year.

Capital Allocation

Share Buybacks

$927.5M

10Y CAGR+16.8%

Equifax Inc spent $927.5M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

$481.4M

YoY-5.9%

5Y CAGR+2.7%

10Y CAGR+12.7%

Equifax Inc invested $481.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 5.9% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

EFX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EFX quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$6.4B	$6.1B+6.9%	$5.7B+7.9%	$5.3B+2.8%	$5.1B+4.0%	$4.9B+19.3%	$4.1B+17.7%	$3.5B+2.8%	$3.4B+1.5%	$3.4B+6.9%	$3.1B+18.1%	$2.7B+9.3%	$2.4B+5.8%	$2.3B+11.1%	$2.1B+9.5%	$1.9B
Cost of Revenue	$2.9B	$2.6B+5.0%	$2.5B+7.9%	$2.3B+7.3%	$2.2B+9.9%	$2.0B+14.0%	$1.7B+14.2%	$1.5B+5.6%	$1.4B+19.0%	$1.2B	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$3.6B	$3.4B+8.4%	$3.2B+7.9%	$2.9B-0.5%	$2.9B+0.1%	$2.9B+23.1%	$2.4B+20.4%	$2.0B+0.7%	$2.0B-8.4%	$2.2B	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$1.7B	$1.6B+11.3%	$1.5B+4.7%	$1.4B+4.3%	$1.3B+0.3%	$1.3B+0.2%	$1.3B-33.5%	$2.0B+64.0%	$1.2B+17.6%	$1.0B+9.7%	$941.0M+6.4%	$884.3M+17.6%	$751.7M+5.0%	$715.8M+6.3%	$673.5M+20.2%	$560.1M
Operating Income	$1.2B	$1.1B+5.1%	$1.0B+11.6%	$933.6M-11.6%	$1.1B-7.2%	$1.1B+68.2%	$676.6M+301.7%	-$335.4M-174.9%	$448.0M-46.1%	$831.7M+0.8%	$825.1M+18.9%	$693.9M+8.7%	$638.2M+4.4%	$611.2M+27.3%	$480.0M+2.4%	$468.6M
Interest Expense	$221.8M	$212.3M-7.3%	$229.1M-5.1%	$241.4M+31.9%	$183.0M+25.7%	$145.6M+2.8%	$141.6M+26.8%	$111.7M+7.9%	$103.5M+11.5%	$92.8M+0.8%	$92.1M+44.4%	$63.8M-7.0%	$68.6M-2.3%	$70.2M+26.7%	$55.4M+0.5%	$55.1M
Income Tax	$244.6M	$230.6M+13.5%	$203.2M+22.3%	$166.2M-27.6%	$229.5M+14.3%	$200.7M+26.2%	$159.0M+545.4%	-$35.7M-166.9%	$53.4M-64.1%	$148.6M-36.3%	$233.1M+15.5%	$201.8M+0.8%	$200.2M+6.0%	$188.9M+21.1%	$156.0M-6.6%	$167.1M
Net Income	$691.3M	$660.3M+9.3%	$604.1M+10.8%	$545.3M-21.7%	$696.2M-6.4%	$744.2M+43.1%	$520.1M+235.4%	-$384.1M-223.7%	$310.5M-47.1%	$587.3M+20.2%	$488.8M+13.9%	$429.1M+16.8%	$367.4M+4.4%	$351.8M+29.3%	$272.1M+16.8%	$232.9M
EPS (Diluted)	$5.68	$5.32+9.9%	$4.84+10.0%	$4.40-22.1%	$5.65-6.1%	$6.02+42.0%	$4.24+234.6%	-$3.15-223.0%	$2.56-47.0%	$4.83+19.6%	$4.04+13.8%	$3.55+19.5%	$2.97+4.6%	$2.84+27.9%	$2.22+18.1%	$1.88

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$1.7B+3.1%	$1.6B+6.3%	$1.6B+0.4%	$1.5B+0.5%	$1.5B+6.6%	$1.4B+1.6%	$1.4B-1.6%	$1.4B
Cost of Revenue	$773.7M+0.9%	$767.1M+16.0%	$661.1M-0.3%	$663.2M-0.2%	$664.6M+1.2%	$656.7M+6.8%	$614.9M-4.7%	$645.2M
Gross Profit	$926.4M+5.1%	$881.8M-0.9%	$889.5M+0.9%	$881.7M+1.1%	$872.4M+11.1%	$785.3M-2.4%	$804.5M+1.0%	$796.6M
SG&A Expenses	$422.5M+2.8%	$411.0M-2.4%	$421.0M-3.0%	$434.1M+13.0%	$384.2M+2.5%	$374.9M+8.7%	$344.9M-9.3%	$380.4M
Operating Income	$314.2M+9.2%	$287.7M+1.2%	$284.3M+7.6%	$264.3M-15.0%	$310.8M+31.8%	$235.8M-18.2%	$288.1M+16.6%	$247.1M
Interest Expense	$59.8M+7.4%	$55.7M+3.0%	$54.1M+3.6%	$52.2M-1.7%	$53.1M+0.4%	$52.9M-5.2%	$55.8M-0.9%	$56.3M
Income Tax	$71.8M+14.9%	$62.5M+10.6%	$56.5M+5.0%	$53.8M-21.7%	$68.7M+33.1%	$51.6M-1.1%	$52.2M+2.2%	$51.1M
Net Income	$183.9M+7.2%	$171.5M-2.4%	$175.7M+9.7%	$160.2M-16.3%	$191.3M+43.7%	$133.1M-23.5%	$174.0M+23.1%	$141.3M
EPS (Diluted)	$1.54+8.5%	$1.42-0.7%	$1.43+10.9%	$1.29-15.7%	$1.53+44.3%	$1.06-24.3%	$1.40+23.9%	$1.13

Not reported in any period shown, so not listed: R&D Expenses.

EFX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EFX quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$11.9B+0.9%	$11.8B-4.2%	$12.3B+6.3%	$11.5B+4.6%	$11.0B+14.9%	$9.6B+21.5%	$7.9B+10.6%	$7.2B-1.1%	$7.2B+8.5%	$6.7B+48.0%	$4.5B-3.4%	$4.7B+2.7%	$4.5B+0.4%	$4.5B+28.5%	$3.5B
Current Assets	$1.4B+3.8%	$1.4B+0.3%	$1.4B-1.0%	$1.4B+22.3%	$1.1B-54.8%	$2.5B+104.9%	$1.2B+34.0%	$902.3M-9.6%	$998.4M+48.4%	$672.9M+19.8%	$561.6M-4.9%	$590.5M-8.9%	$648.4M+20.4%	$538.7M+17.9%	$456.9M
Cash & Equivalents	$180.8M+6.4%	$169.9M-21.6%	$216.8M-24.0%	$285.2M+26.9%	$224.7M-86.7%	$1.7B+319.8%	$401.3M+79.5%	$223.6M-33.5%	$336.4M+160.2%	$129.3M+38.6%	$93.3M-27.3%	$128.3M-45.6%	$235.9M+60.7%	$146.8M+15.0%	$127.7M
Accounts Receivable	$1.0B+5.8%	$957.6M+5.4%	$908.2M+5.9%	$857.7M+17.9%	$727.6M+15.4%	$630.6M+18.5%	$532.1M+13.4%	$469.1M+5.5%	$444.8M+2.7%	$433.3M+23.9%	$349.8M+3.7%	$337.2M+8.9%	$309.7M-2.3%	$317.0M+11.5%	$284.4M
Goodwill	$6.7B+3.0%	$6.5B-4.1%	$6.8B+7.0%	$6.4B+2.0%	$6.3B+39.2%	$4.5B+4.4%	$4.3B+4.3%	$4.1B-1.3%	$4.2B+5.3%	$4.0B+54.6%	$2.6B-1.4%	$2.6B+8.8%	$2.4B+4.6%	$2.3B+16.8%	$2.0B
Total Liabilities	$7.1B+4.2%	$6.8B-9.9%	$7.6B+0.2%	$7.6B+1.8%	$7.4B+16.2%	$6.4B+21.1%	$5.3B+32.2%	$4.0B+0.1%	$4.0B+1.3%	$3.9B+83.3%	$2.2B-11.3%	$2.4B+10.3%	$2.2B-14.1%	$2.6B+42.5%	$1.8B
Current Liabilities	$2.3B+28.9%	$1.8B-10.3%	$2.0B+0.2%	$2.0B-12.0%	$2.3B-7.7%	$2.5B+82.7%	$1.4B+64.4%	$826.8M-50.6%	$1.7B+32.9%	$1.3B+108.6%	$603.8M-26.6%	$823.1M+24.2%	$662.5M+2.5%	$646.5M+77.2%	$364.9M
Long-Term Debt	$4.1B-6.2%	$4.3B-9.0%	$4.7B-1.5%	$4.8B+7.8%	$4.5B+36.4%	$3.3B-3.0%	$3.4B+28.5%	$2.6B+51.3%	$1.7B-16.7%	$2.1B+83.3%	$1.1B-0.6%	$1.1B0.0%	$1.1B-20.9%	$1.4B+49.8%	$966.0M
Total Equity	$4.6B-4.0%	$4.8B+5.8%	$4.5B+14.6%	$4.0B+10.4%	$3.6B+13.1%	$3.2B+22.9%	$2.6B-17.0%	$3.1B-2.1%	$3.2B+19.2%	$2.7B+15.2%	$2.3B+5.0%	$2.2B-4.4%	$2.3B+19.0%	$1.9B+13.6%	$1.7B
Retained Earnings	$6.4B+7.1%	$6.0B+7.3%	$5.6B+6.7%	$5.3B+10.6%	$4.8B+13.5%	$4.2B+8.6%	$3.9B-18.3%	$4.7B+2.5%	$4.6B+10.8%	$4.2B+8.3%	$3.8B+7.9%	$3.6B+7.4%	$3.3B+8.0%	$3.1B+6.4%	$2.9B

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$12.0B+0.3%	$11.9B+0.7%	$11.9B+0.3%	$11.8B-0.7%	$11.9B+0.5%	$11.9B+0.8%	$11.8B-4.7%	$12.3B
Current Assets	$1.6B+6.4%	$1.5B+5.3%	$1.4B-3.5%	$1.5B-2.6%	$1.5B+1.8%	$1.5B+8.5%	$1.4B-17.7%	$1.7B
Cash & Equivalents	$170.1M-7.3%	$183.4M+1.4%	$180.8M-4.3%	$189.0M0.0%	$189.0M-3.2%	$195.2M+14.9%	$169.9M-63.7%	$468.2M
Accounts Receivable	$1.1B+3.0%	$1.1B+5.8%	$1.0B-0.2%	$1.0B-2.3%	$1.0B+2.1%	$1.0B+6.3%	$957.6M+0.4%	$953.6M
Goodwill	$6.8B0.0%	$6.8B+0.7%	$6.7B+1.2%	$6.7B+0.1%	$6.7B+1.0%	$6.6B+0.7%	$6.5B-2.7%	$6.7B
Total Liabilities	$7.5B+2.8%	$7.3B+1.9%	$7.1B+5.5%	$6.8B+1.1%	$6.7B-0.9%	$6.7B-1.4%	$6.8B-6.3%	$7.3B
Current Liabilities	$2.6B+7.1%	$2.5B+4.9%	$2.3B+17.7%	$2.0B+2.0%	$1.9B+12.4%	$1.7B-4.4%	$1.8B-3.4%	$1.9B
Long-Term Debt	$4.1B0.0%	$4.1B0.0%	$4.1B0.0%	$4.1B+0.1%	$4.1B-6.3%	$4.3B0.0%	$4.3B-8.4%	$4.7B
Total Equity	$4.4B-3.5%	$4.5B-1.4%	$4.6B-6.8%	$4.9B-3.2%	$5.1B+2.5%	$5.0B+3.8%	$4.8B-2.3%	$4.9B
Retained Earnings	$6.7B+1.8%	$6.5B+1.6%	$6.4B+1.8%	$6.3B+1.6%	$6.2B+2.1%	$6.1B+1.4%	$6.0B+2.1%	$5.9B

Not reported in any period shown, so not listed: Inventory.

EFX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EFX quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$1.6B	$1.6B+22.0%	$1.3B+18.6%	$1.1B+47.5%	$757.1M-43.3%	$1.3B+41.1%	$946.2M+201.5%	$313.8M-53.3%	$672.2M-17.6%	$816.0M-0.9%	$823.0M+7.0%	$769.1M+24.8%	$616.2M+8.3%	$569.0M+14.6%	$496.3M+21.4%	$408.7M
Capital Expenditures	$507.4M	$481.4M-5.9%	$511.5M-14.9%	$601.3M-3.7%	$624.5M+33.2%	$469.0M+11.3%	$421.3M+5.4%	$399.6M+24.1%	$321.9M+47.5%	$218.2M+25.8%	$173.5M+18.7%	$146.2M+69.2%	$86.4M+3.7%	$83.3M+26.2%	$66.0M-12.0%	$75.0M
Free Cash Flow	$1.1B	$1.1B+39.5%	$813.0M+57.7%	$515.5M+288.8%	$132.6M-84.7%	$865.8M+64.9%	$524.9M+711.8%	-$85.8M-124.5%	$350.3M-41.4%	$597.8M-8.0%	$649.5M+4.3%	$622.9M+17.6%	$529.8M+9.1%	$485.7M+12.9%	$430.3M+28.9%	$333.7M
Investing Cash Flow	-$581.1M	-$554.3M-8.4%	-$511.5M+41.8%	-$878.2M+8.5%	-$959.5M+71.8%	-$3.4B-589.7%	-$492.7M+29.4%	-$697.5M-51.1%	-$461.5M-32.0%	-$349.5M+82.3%	-$2.0B-1236.9%	-$147.8M+65.6%	-$429.3M-215.0%	-$136.3M+87.4%	-$1.1B-430.9%	-$204.1M
Financing Cash Flow	-$1.0B	-$1.1B-25.2%	-$846.4M-176.4%	-$306.2M-211.9%	$273.7M-55.7%	$617.7M-23.8%	$810.8M+45.3%	$557.9M+279.4%	-$311.0M-17.9%	-$263.7M-122.7%	$1.2B+281.6%	-$639.0M-125.5%	-$283.4M+14.9%	-$333.1M-154.9%	$606.3M+409.5%	-$195.9M
Dividends Paid	$255.8M	$232.8M+20.5%	$193.2M+0.7%	$191.8M+0.4%	$191.1M+0.6%	$190.0M+0.3%	$189.5M+0.4%	$188.7M+0.4%	$187.9M+0.3%	$187.4M+18.9%	$157.6M+14.4%	$137.8M+13.7%	$121.2M+13.6%	$106.7M+24.1%	$86.0M+10.1%	$78.1M
Share Buybacks	$1.4B	$927.5M	$0	$0	$0-100.0%	$69.9M	$0	$0	$0-100.0%	$77.1M	$0-100.0%	$196.3M-34.9%	$301.6M+2434.5%	$11.9M-86.0%	$85.1M-40.2%	$142.3M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$339.8M+40.5%	$241.9M-48.6%	$470.8M-15.9%	$559.9M+55.1%	$361.1M+61.3%	$223.9M-31.1%	$324.8M-32.3%	$479.5M
Capital Expenditures	$135.0M+12.1%	$120.4M-7.4%	$130.0M+6.6%	$122.0M-0.2%	$122.2M+14.0%	$107.2M-9.8%	$118.9M-4.1%	$124.0M
Free Cash Flow	$204.8M+68.6%	$121.5M-64.3%	$340.8M-22.2%	$437.9M+83.3%	$238.9M+104.7%	$116.7M-43.3%	$205.9M-42.1%	$355.5M
Investing Cash Flow	-$135.0M-12.1%	-$120.4M+40.9%	-$203.7M-67.0%	-$122.0M-0.5%	-$121.4M-13.2%	-$107.2M+9.8%	-$118.9M+4.1%	-$124.0M
Financing Cash Flow	-$217.2M-84.5%	-$117.7M+57.4%	-$276.2M+36.8%	-$436.7M-74.0%	-$251.0M-162.0%	-$95.8M+80.9%	-$501.4M-679.8%	-$64.3M
Dividends Paid	$66.4M-1.0%	$67.1M+10.4%	$60.8M-1.1%	$61.5M-0.8%	$62.0M+27.8%	$48.5M+0.2%	$48.4M0.0%	$48.4M
Share Buybacks	$300.0M+15.4%	$260.0M-48.0%	$500.1M+66.7%	$300.0M+135.5%	$127.4M	$0	$0	$0

EFX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

EFX quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Gross Margin	56.5%+0.8pp	55.7%0.0pp	55.6%-1.8pp	57.5%-2.3pp	59.8%+1.9pp	57.9%+1.3pp	56.6%-1.2pp	57.8%-6.2pp	64.0%	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	18.0%-0.3pp	18.3%+0.6pp	17.7%-2.9pp	20.6%-2.5pp	23.1%+6.7pp	16.4%+25.9pp	-9.6%-22.7pp	13.1%-11.6pp	24.7%-1.5pp	26.2%+0.2pp	26.1%-0.1pp	26.2%-0.3pp	26.5%+3.4pp	23.2%-1.6pp	24.8%
Net Margin	10.9%+0.2pp	10.6%+0.3pp	10.4%-3.2pp	13.6%-1.5pp	15.1%+2.5pp	12.6%+23.5pp	-10.9%-20.1pp	9.1%-8.4pp	17.5%+1.9pp	15.5%-0.6pp	16.1%+1.0pp	15.1%-0.2pp	15.3%+2.1pp	13.1%+0.8pp	12.3%
Return on Equity	14.3%+1.7pp	12.6%+0.6pp	12.0%-5.6pp	17.6%-3.2pp	20.8%+4.3pp	16.4%+31.3pp	-14.9%-24.9pp	10.0%-8.5pp	18.5%+0.1pp	18.4%-0.2pp	18.6%+1.9pp	16.7%+1.4pp	15.3%+1.2pp	14.1%+0.4pp	13.7%
Return on Assets	5.6%+0.4pp	5.1%+0.7pp	4.4%-1.6pp	6.0%-0.7pp	6.7%+1.3pp	5.4%+10.3pp	-4.9%-9.2pp	4.3%-3.8pp	8.1%+0.8pp	7.3%-2.2pp	9.5%+1.7pp	7.9%+0.1pp	7.8%+1.7pp	6.0%-0.6pp	6.6%
Current Ratio	0.60-0.1x	0.75+0.1x	0.670.0x	0.68+0.2x	0.49-0.5x	1.00+0.1x	0.89-0.2x	1.09+0.5x	0.60+0.1x	0.53-0.4x	0.93+0.2x	0.72-0.3x	0.98+0.1x	0.83-0.4x	1.25
Debt-to-Equity	0.880.0x	0.90-0.1x	1.05-0.2x	1.220.0x	1.25+0.2x	1.03-0.3x	1.31+0.5x	0.85+0.3x	0.55-0.2x	0.78+0.3x	0.490.0x	0.520.0x	0.50-0.3x	0.75+0.2x	0.57
FCF Margin	18.7%+4.4pp	14.3%+4.5pp	9.8%+7.2pp	2.6%-15.0pp	17.6%+4.9pp	12.7%+15.2pp	-2.5%-12.7pp	10.3%-7.5pp	17.8%-2.9pp	20.6%-2.7pp	23.4%+1.6pp	21.8%+0.7pp	21.1%+0.3pp	20.8%+3.1pp	17.6%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	54.5%+1.0pp	53.5%-3.9pp	57.4%+0.3pp	57.1%+0.3pp	56.8%+2.3pp	54.5%-2.2pp	56.7%+1.4pp	55.3%
Operating Margin	18.5%+1.0pp	17.4%-0.9pp	18.3%+1.2pp	17.1%-3.1pp	20.2%+3.9pp	16.4%-4.0pp	20.3%+3.2pp	17.1%
Net Margin	10.8%+0.4pp	10.4%-0.9pp	11.3%+1.0pp	10.4%-2.1pp	12.4%+3.2pp	9.2%-3.0pp	12.3%+2.5pp	9.8%
Return on Equity	4.2%+0.4pp	3.8%0.0pp	3.8%+0.6pp	3.2%-0.5pp	3.8%+1.1pp	2.7%-1.0pp	3.6%+0.8pp	2.9%
Return on Assets	1.5%+0.1pp	1.4%0.0pp	1.5%+0.1pp	1.4%-0.3pp	1.6%+0.5pp	1.1%-0.4pp	1.5%+0.3pp	1.1%
Current Ratio	0.600.0x	0.610.0x	0.60-0.1x	0.740.0x	0.77-0.1x	0.85+0.1x	0.75-0.1x	0.88
Debt-to-Equity	0.930.0x	0.890.0x	0.88+0.1x	0.820.0x	0.79-0.1x	0.870.0x	0.90-0.1x	0.96
FCF Margin	12.0%+4.7pp	7.4%-14.6pp	22.0%-6.4pp	28.3%+12.8pp	15.5%+7.5pp	8.1%-6.4pp	14.5%-10.2pp	24.7%

Note: The current ratio is below 1.0 (0.60), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Verisk Analytics VRSK

$25.0B

Booz Allen Hamilton Hldg Corp BAH

$9.1B

Fti Consulting Inc FCN

$4.2B

Huron Consul HURN

$2.5B

RB Global RBA

$15.9B

Where Equifax Inc Ranks

Frequently Asked Questions

What is Equifax Inc's annual revenue?

Equifax Inc (EFX) reported $6.1B in total revenue for fiscal year 2025. This represents a 6.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Equifax Inc's revenue growing?

Equifax Inc (EFX) revenue grew by 6.9% year-over-year, from $5.7B to $6.1B in fiscal year 2025.

Is Equifax Inc profitable?

Yes, Equifax Inc (EFX) reported a net income of $660.3M in fiscal year 2025, with a net profit margin of 10.9%.

What is Equifax Inc's EBITDA?

Equifax Inc (EFX) had EBITDA of $1.8B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Equifax Inc have?

As of fiscal year 2025, Equifax Inc (EFX) had $180.8M in cash and equivalents against $4.1B in long-term debt.

What is Equifax Inc's gross margin?

Equifax Inc (EFX) had a gross margin of 56.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Equifax Inc's operating margin?

Equifax Inc (EFX) had an operating margin of 18.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Equifax Inc's net profit margin?

Equifax Inc (EFX) had a net profit margin of 10.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Equifax Inc pay dividends?

Yes, Equifax Inc (EFX) paid $1.89 per share in dividends during fiscal year 2025.

What is Equifax Inc's return on equity (ROE)?

Equifax Inc (EFX) has a return on equity of 14.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Equifax Inc's free cash flow?

Equifax Inc (EFX) generated $1.1B in free cash flow during fiscal year 2025. This represents a 39.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Equifax Inc's operating cash flow?

Equifax Inc (EFX) generated $1.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Equifax Inc's total assets?

Equifax Inc (EFX) had $11.9B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Equifax Inc's capital expenditures?

Equifax Inc (EFX) invested $481.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Equifax Inc buy back shares?

Yes, Equifax Inc (EFX) spent $927.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Equifax Inc have outstanding?

Equifax Inc (EFX) had 120M shares outstanding as of fiscal year 2025.

What is Equifax Inc's current ratio?

Equifax Inc (EFX) had a current ratio of 0.60 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Equifax Inc's debt-to-equity ratio?

Equifax Inc (EFX) had a debt-to-equity ratio of 0.88 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Equifax Inc's return on assets (ROA)?

Equifax Inc (EFX) had a return on assets of 5.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Equifax Inc's Altman Z-Score?

Equifax Inc (EFX) has an Altman Z-Score of 3.41, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Equifax Inc's Piotroski F-Score?

Equifax Inc (EFX) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Equifax Inc's earnings high quality?

Equifax Inc (EFX) has an earnings quality ratio of 2.45x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Equifax Inc cover its interest payments?

Equifax Inc (EFX) has an interest coverage ratio of 5.16x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Equifax Inc?

Equifax Inc (EFX) scores 56 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.